Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

1754studies shown

Showing 1,033-1,044 of 1,754

Drug study icon

RecruitingNCT07325279

Nalmefene Implant in Healthy Subjects

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 18 Years

Countries: United States
Sponsor: ReacX Pharmaceuticals, Inc.
Condition: Addiction

Drug study icon

RecruitingNCT05028062

Naltrexone in AUD Reward Drinkers

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Pennsylvania
Condition: Addiction

Drug study icon

RecruitingNCT05509257

Naltrexone Neuroimaging in Teens With Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 13 Years to 21 Years

Countries: United States
Sponsor: Children's Mercy Hospital Kansas City
Condition: Eating disorders

Other study type icon

RecruitingNCT01246765

National Pregnancy Registry for Psychiatric Medications

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDObservationalFrom 18 Years to 45 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: ADHD

Behavioral study icon

RecruitingNCT05224440

National Sponsorship Program for Transitioning Service Members

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SuicidalityBehavioralOver 18 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: Suicidality

Behavioral study icon

RecruitingNCT06785311

Native Spirit: Significant Aim 3: Intervention

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 12 Years to 17 Years

Countries: United States
Sponsor: Arizona State University
Condition: Addiction

Other study type icon

RecruitingNCT06462196

Natural History of Depression, Bipolarity and Suicide prevention

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, Bipolarity, ...ObservationalFrom 18 Years to 120 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Depression, Bipolarity, ...

Behavioral study icon

RecruitingNCT07262190

NavSTAR Implementation Effectiveness study Across a Health System

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: Friends Research Institute, Inc.
Condition: Addiction

Drug study icon

RecruitingNCT06911112

NBI-1065845 for depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Bulgaria, in Lithuania, ...

In United States

DepressionDrugOver 18 Years

Countries: United States, Bulgaria, Lithuania, ...
Sponsor: Neurocrine Biosciences
Condition: Depression

Drug study icon

RecruitingNCT06963021

NBI-1065845 for depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Canada, in the United Kingdom, ...

In United States

DepressionDrugOver 18 Years

Countries: United States, Canada, United Kingdom, ...
Sponsor: Neurocrine Biosciences
Condition: Depression

Drug study icon

RecruitingNCT06963034

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Neurocrine Biosciences
Condition: Schizophrenia

Drug study icon

RecruitingNCT07105098

NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States, Bulgaria, Hungary, ...
Sponsor: Neurocrine Biosciences
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.